E-LIB Suche - Ergebnisse für: Craxì, A.

1

Eliminating HCV infection from prisons in sicily: the SINTE..:

Di Marco, L. ; Cartabellotta, F. ; Santangelo, F....
Digestive and Liver Disease. 56 (2024) - p. S15 , 2024

Link: https://doi.org/10.1016/..

2

The equitable benefit approach (EBA): a single ethical fram..:

Craxì, L. ; Cottone, P.M. ; Sacchini, D...
Digestive and Liver Disease. 56 (2024) - p. S39 , 2024

Link: https://doi.org/10.1016/..

3

Programmed cell death 1 genetic variant and liver damage in..:

Pipitone, R.M. ; Malvestiti, F. ; Pennisi, G....
Digestive and Liver Disease. 55 (2023) - p. S7-S8 , 2023

Link: https://doi.org/10.1016/..

4

Presence and severity of esophageal varices drives portal h..:

Pennisi, G. ; Enea, M. ; Viganò, M....
Digestive and Liver Disease. 55 (2023) - p. S21 , 2023

Link: https://doi.org/10.1016/..

5

RESIST Criteria: A biochemical algorithm to reduce the numb..:

Calvaruso, V. ; Celsa, C. ; Degasperi, E....
Digestive and Liver Disease. 55 (2023) - p. S38 , 2023

Link: https://doi.org/10.1016/..

6

SIRT5 rs12216101 T>G variant is associated with oxidative s..:

Salomone, F. ; Pipitone, R.M. ; Longo, M....
Digestive and Liver Disease. 55 (2023) - p. S2 , 2023

Link: https://doi.org/10.1016/..

7

OC.12.2 RESIST CRITERIA: A BIOCHEMICAL ALGORITHM TO REDUCE ..:

Calvaruso, V. ; Celsa, C. ; Degasperi, E....
Digestive and Liver Disease. 55 (2023) - p. S118-S119 , 2023

Link: https://doi.org/10.1016/..

8

OC.08.1 PROGRAMMED CELL DEATH 1 GENETIC VARIANT AND LIVER D..:

Pipitone, R.M. ; Malvestiti, F. ; Pennisi, G....
Digestive and Liver Disease. 55 (2023) - p. S105 , 2023

Link: https://doi.org/10.1016/..

9

Pharmacological interventions effect on liver histology in ..:

Pennisi, G. ; Celsa, C. ; Enea, M....
Digestive and Liver Disease. 54 (2022) - p. S33 , 2022

Link: https://doi.org/10.1016/..

10

Ruling out Varices Needing Treatment with a non-invasive sc..:

Rizzo, G. ; Graceffa, P. ; Falco, G....
Digestive and Liver Disease. 54 (2022) - p. S58 , 2022

Link: https://doi.org/10.1016/..

11

Gamma Glutamyl Transferase as a marker of risk of progressi..:

Calvaruso, V. ; Saitta, C. ; Russello, M....
Digestive and Liver Disease. 54 (2022) - p. S12 , 2022

Link: https://doi.org/10.1016/..

12

AGILE-3 Score for the diagnosis of advanced fibrosis and fo..:

Pennisi, G. ; Enea, M. ; Pandolfo, A....
Digestive and Liver Disease. 54 (2022) - p. S17-S18 , 2022

Link: https://doi.org/10.1016/..

13

Outcomes of three lines Atezolizumab plus Bevacizumab-based..:

Celsa, C. ; Cabibbo, G. ; Battaglia, S....
Digestive and Liver Disease. 54 (2022) - p. S52-S53 , 2022

Link: https://doi.org/10.1016/..

14

Efficacy and safety of pangenotypic DAAs for chronic HCV in..:

Salomone, F. ; Cacciola, I. ; Petta, S....
Digestive and Liver Disease. 54 (2022) - p. S55-S56 , 2022

Link: https://doi.org/10.1016/..

15

New onset steatosis but not persistent steatosis prevents h..:

Cespiati, A. ; Petta, S. ; Lombardi, R....
Digestive and Liver Disease. 53 (2021) - p. S16 , 2021

Link: https://doi.org/10.1016/..